Intermediate prostate cancer generally means that the tumor has broken through the peritoneum of the prostate but has not yet metastasized. Surgery is generally recommended, and those who are not suitable for surgery can be treated with medication, and its 5-10 years survival rate can reach 70%~80%.
In this period of prostate cancer, radical prostate cancer surgery is usually carried out, which is mainly to remove the prostate and seminal vesicles, while the urinary pathway reconstruction is carried out afterward, and the surgical methods usually include traditional open surgery, laparoscopic surgery, and so on. Among them is laparoscopic resection surgery currently more commonly used radical prostate cancer surgery.
If the patient can not tolerate surgery, can be performed drug treatment, recommended anti-androgenic and de-estrogenic treatment at the same time, such as bicalutamide, goserelin acetate and so on.
Generally after active treatment, the result is better, even can be cured, generally 5~10 years survival rate can reach 70%~80%. It is recommended that patients undergo prostate-specific antigen and anal diagnostic examination every three months after treatment, and can be tested every six months after two years and annually after five years.
It is recommended that patients be treated in a timely manner to avoid aggravation of the condition and affecting the prognosis, and also follow the doctor’s instructions for review and monitoring of changes in the body so that timely treatment can be carried out.